Nanomedicine in Cancer Immunotherapy

— —

Prashant Kesharwani, PhD (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)

Nanomedicine in Cancer Immunotherapy

Prashant Kesharwani, PhD (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)

$440.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
19 January 2024

Immunology; Biomedical engineering; Biotechnology; Materials science

Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often personalized to the patient. The book covers a wide range of nanomaterial types for use in cancer immunotherapy, including hydrogel, lipid, exosome, gold and peptide nanoparticles. The preparation, application, pros and cons of each nanomaterial class is reviewed, helping the reader understand the potential for each to tailor their own selections. Nanovaccines are also covered, along with a clinical evaluation and market analysis of nanomedicines for immunotherapy, offering an important clinical and commercial overview of this rapidly developing field.

This book is an interesting reference for those working in the fields of nanotechnology, immunology, and cancer therapeutics, as well as clinicians with an interest in novel nano-based cancer treatments.

Edited by: Prashant Kesharwani PhD (Assistant Professor Department of Pharmaceutics School of Pharmaceutical Education and Research Jamia Hamdard New Delhi India)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 229mm, Width: 152mm,
Weight: 1.000kg
ISBN: 9780443187704
ISBN 10: 0443187703
Pages: 500
Publication Date: 19 January 2024
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

1. Immunoadjuvants for cancer immunotherapy 2. Nanotechnology as an emerging option in cancer immunotherapy 3. Different administration routes for nanovectors in cancer immunotherapy 4. Two-dimensional materialbased nanomedicines for cancer immunotherapy 5. Hydrogel-based nanomedicines for cancer immunotherapy 6. Exosomes-based nanomedicines for cancer immunotherapy 7. Lipid-based nanomedicines for cancer immunotherapy 8. Inorganic nanoparticle-based nanomedicines for cancer immunotherapy 9. Liposome-based nanomedicines for cancer immunotherapy 10. Biomembrane-based nanoparticles for cancer immunotherapy 11. Dendrimer-based nanomedicines for cancer immunotherapy 12. Magnetic nanocarriers for cancer immunotherapy 13. Inhaled delivery of immunotherapy for treatment of lung cancer 14. Nano-based vaccination and their administration routes in cancer immunotherapy 15. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy

Dr. Prashant Kesharwani is working as an assistant professor of pharmaceutics at the School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 20 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also a receipt of several internationally acclaimed awards such as the most prestigious “Ramanujan Fellowship Award from the Science and Engineering Research Board, Government of India. He actively participates in outreach and scientific dissemination for the service of the wider community.